secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surrozen, Inc./DE (SRZN)
CIK:        0001824893
Form:       8-K
Filed at:   2021-08-12T23:59:59+00:00
Accession:  0001193125-21-244260
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surrozen completes SPAC merger; Nasdaq listing under SRZN/SRZNW on Aug 12
-------------------------------------------------------------------------

- Business combination with Consonance-HFW Acquisition Corp. closed August 11, 2021.
- Common stock and warrants start trading on Nasdaq August 12 under SRZN and SRZNW.
- Transaction approved by Consonance-HFW shareholders on August 10 and Surrozen stockholders.
- Existing management, led by CEO Craig Parker, to continue leading the combined company.
- Surrozen focuses on Wnt pathway therapeutics for tissue repair and regeneration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824893/000119312521244260/0001193125-21-244260-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824893/000119312521244260/d148870d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-244260

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer